Spur Therapeutics is based in Boston, MA. It has raised $274M in total funding. Backed by Syncona, Novo Holdings, Eventide Asset Management.
Spur Therapeutics funding overview
Spur Therapeutics is based in Boston, MA. Spur Therapeutics has raised $274M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Investors on record include Syncona, Novo Holdings, Eventide Asset Management, Wellington Management Company, The UCL Technology Fund, Mass General Brigham Ventures. 6 distinct backers are named across the disclosed rounds.
Spur Therapeutics at a glance
Total raised
$274M
Headquarters
Boston, MA
Notable investors
Syncona, Novo Holdings, Eventide Asset Management, Wellington Management Company, The UCL Technology Fund, Mass General Brigham Ventures
Frequently asked about Spur Therapeutics funding
How much has Spur Therapeutics raised?
Spur Therapeutics has raised $274M in total disclosed funding across the rounds on record.
Who has invested in Spur Therapeutics?
Syncona, Novo Holdings, Eventide Asset Management, Wellington Management Company, The UCL Technology Fund, Mass General Brigham Ventures are named among the investors backing Spur Therapeutics.
What was the latest Spur Therapeutics funding round?
No round stage has been disclosed for Spur Therapeutics.
Where is Spur Therapeutics based?
Spur Therapeutics is based in Boston, MA.
We update the Spur Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.
